Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Capital Expenditure Over TimeContracting
Percentile Rank40
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-2.59M
Near historical average
Percentile
P40
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-2.47M
Historical baseline
PeriodValueYoY Change
TTM$-2.59M-303.0%
2024$-642000.00+80.3%
2023$-3.26M+48.3%
2022$-6.30M-265.4%
2021$-1.72M-507.0%
2020$-284000.00-